This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2017 Nov;14(11):631.

doi: 10.1038/nrgastro.2017.144. Epub 2017 Oct 11.

NAFLD: Early promise for ASK1 inhibition in NASH

PMID: 29018270
DOI: 10.1038/nrgastro.2017.144

Comment

NAFLD: Early promise for ASK1 inhibition in NASH

Katrina Ray. Nat Rev Gastroenterol Hepatol. 2017 Nov.

. 2017 Nov;14(11):631.

doi: 10.1038/nrgastro.2017.144. Epub 2017 Oct 11.

Author

PMID: 29018270
DOI: 10.1038/nrgastro.2017.144

No abstract available

PubMed Disclaimer

Comment on

The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trial.
Loomba R, Lawitz E, Mantry PS, Jayakumar S, Caldwell SH, Arnold H, Diehl AM, Djedjos CS, Han L, Myers RP, Subramanian GM, McHutchison JG, Goodman ZD, Afdhal NH, Charlton MR; GS-US-384-1497 Investigators. Loomba R, et al. Hepatology. 2018 Feb;67(2):549-559. doi: 10.1002/hep.29514. Epub 2017 Dec 26. Hepatology. 2018. PMID: 28892558 Free PMC article. Clinical Trial.

References

1. Hepatology. 2017 Sep 11;:null - PubMed

Publication types

Actions

MeSH terms

Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal